4-azido-7-phenylpyrazolo-(1,5a)-1,3,5-triazine has been researched along with papaverine in 1 studies
Studies (4-azido-7-phenylpyrazolo-(1,5a)-1,3,5-triazine) | Trials (4-azido-7-phenylpyrazolo-(1,5a)-1,3,5-triazine) | Recent Studies (post-2010) (4-azido-7-phenylpyrazolo-(1,5a)-1,3,5-triazine) | Studies (papaverine) | Trials (papaverine) | Recent Studies (post-2010) (papaverine) |
---|---|---|---|---|---|
12 | 1 | 1 | 6,027 | 305 | 355 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (100.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Duemler, BH; Keravis, TM; Kuttesch, NJ; Sullivan, TA; Wells, JN | 1 |
1 other study(ies) available for 4-azido-7-phenylpyrazolo-(1,5a)-1,3,5-triazine and papaverine
Article | Year |
---|---|
Irreversible inhibition of calmodulin-sensitive cyclic nucleotide phosphodiesterase.
Topics: 1-Methyl-3-isobutylxanthine; 3',5'-Cyclic-AMP Phosphodiesterases; Affinity Labels; Animals; Calmodulin; Cerebral Cortex; Chymotrypsin; Cyclic AMP; Cyclic GMP; Papaverine; Photolysis; Swine; Triazines; Ultraviolet Rays | 1986 |